Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  pegylated interferon alfa
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: EORTC-18991, NCT00006249
STI571 ProspectIve RandomIzed Trial: SPIRIT
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 030482, NCT00219739
Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0450, NCI-2010-01030, NCT00791271
A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: 020193, 02-C-0193, NCI-02-C-0193, NCT00041145, NCT00036569
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: Other
Protocol IDs: MEL06, NCI-2011-01192, NCT00539591
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Completed
Age: No age specified
Sponsor: NCI, Other
Protocol IDs: VICC MEL0651, VU-VICC-MEL-0651, VU-VICC-060614, NCT00897312
Start Over